287 related articles for article (PubMed ID: 22489829)
1. Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection.
Tang Y; Jiang L; Zheng Y; Ni B; Wu Y
BMC Immunol; 2012 Apr; 13():17. PubMed ID: 22489829
[TBL] [Abstract][Full Text] [Related]
2. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.
Dong X; Gong Y; Zeng H; Hao Y; Wang X; Hou J; Wang J; Li J; Zhu Y; Liu H; Han J; Zhou H; Shen L; Gao T; Zhou T; Yang S; Li S; Chen Y; Meng Q; Li H
Liver Int; 2013 Nov; 33(10):1517-26. PubMed ID: 23869954
[TBL] [Abstract][Full Text] [Related]
3. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
[TBL] [Abstract][Full Text] [Related]
4. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.
Xu D; Fu J; Jin L; Zhang H; Zhou C; Zou Z; Zhao JM; Zhang B; Shi M; Ding X; Tang Z; Fu YX; Wang FS
J Immunol; 2006 Jul; 177(1):739-47. PubMed ID: 16785573
[TBL] [Abstract][Full Text] [Related]
5. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
Shen C; Yan WZ; Zhao CY; Che HH; Liu XY; Liu ZZ; Wang YD; Wang W; Li M; Gao J
J Microbiol Immunol Infect; 2015 Apr; 48(2):137-46. PubMed ID: 24388581
[TBL] [Abstract][Full Text] [Related]
6. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.
Xue-Song L; Cheng-Zhong L; Ying Z; Mo-Bin W
BMC Gastroenterol; 2012 May; 12():43. PubMed ID: 22548790
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
Schulze Zur Wiesch J; Thomssen A; Hartjen P; Tóth I; Lehmann C; Meyer-Olson D; Colberg K; Frerk S; Babikir D; Schmiedel S; Degen O; Mauss S; Rockstroh J; Staszewski S; Khaykin P; Strasak A; Lohse AW; Fätkenheuer G; Hauber J; van Lunzen J
J Virol; 2011 Feb; 85(3):1287-97. PubMed ID: 21047964
[TBL] [Abstract][Full Text] [Related]
8. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
9. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
10. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure.
Zhai S; Zhang L; Dang S; Yu Y; Zhao Z; Zhao W; Liu L
Viral Immunol; 2011 Aug; 24(4):303-10. PubMed ID: 21721931
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-35 modulates the balance between viral specific CD4
Yang L; Jia S; Shao X; Liu S; Zhang Q; Song J; Wang W; Jin Z
Virol J; 2019 Apr; 16(1):48. PubMed ID: 30992023
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
13. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
Deng M; Li MH; Liu SA; Liu F; Sang Y; Song SJ; Zang SF; Guan XP; Yao X; Wu XP; Cheng J; Xu DZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):21-3. PubMed ID: 20848841
[TBL] [Abstract][Full Text] [Related]
14. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
Åkesson K; Tompa A; Rydén A; Faresjö M
Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
[TBL] [Abstract][Full Text] [Related]
15. Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.
Wang L; Qiu J; Yu L; Hu X; Zhao P; Jiang Y
J Transl Med; 2014 Sep; 12():251. PubMed ID: 25199644
[TBL] [Abstract][Full Text] [Related]
16. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
[TBL] [Abstract][Full Text] [Related]
17. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.
Peng G; Li S; Wu W; Sun Z; Chen Y; Chen Z
Immunology; 2008 Jan; 123(1):57-65. PubMed ID: 17764450
[TBL] [Abstract][Full Text] [Related]
18. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.
El-Badawy O; Sayed D; Badary MS; Abd-Alrahman ME; El-Feky MA; Thabit AG
Hum Immunol; 2012 Apr; 73(4):335-41. PubMed ID: 22342871
[TBL] [Abstract][Full Text] [Related]
19. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF
Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation.
Koay LB; Feng IC; Sheu MJ; Kuo HT; Lin CY; Chen JJ; Wang SL; Tang LY; Tsai SL
Hum Immunol; 2011 Sep; 72(9):687-98. PubMed ID: 21215784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
